Company performance
Add to research
Current Price
as of May 19, 2025$8.93
P/E Ratio
N/A
Market Cap
$1.11B
Description
Add to research
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Metrics
Add to research
Overview
- HQPleasanton, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerTXG
- Price$8.93-4.90%
Trading Information
- Market cap$1.11B
- Float82.85%
- Average Daily Volume (1m)3,898,884
- Average Daily Volume (3m)3,625,658
- EPS-$1.30
Company
- Revenue$624.66M
- Rev growth (1yr)9.84%
- Net income-$34.36M
- Gross margin70.64%
- EBITDA margin-24.93%
- EBITDA-$38.61M
- EV$723.52M
- EV/Revenue1.16
- P/EN/A
- P/S1.75
- P/B1.56
- Debt/Equity11.33
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset